{"id":50771,"date":"2023-09-20T09:12:58","date_gmt":"2023-09-20T09:12:58","guid":{"rendered":"https:\/\/medsname.com\/trajenta\/"},"modified":"2026-05-01T10:49:11","modified_gmt":"2026-05-01T10:49:11","slug":"trajenta","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/trajenta\/","title":{"rendered":"Trajenta"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Trajenta?<\/h3>\n<p style=\"margin:0;\"><strong>Trajenta<\/strong> je zna\u010dka <strong>linagliptin<\/strong> (5 mg), <strong>inhibitor DPP-4<\/strong> (dipeptidyl peptid\u00e1za-4 inhibitor, tak\u00e9 naz\u00fdvan\u00fd \u201cgliptin\u201d) pou\u017e\u00edvan\u00fd k <strong>diabetu 2. typu<\/strong>. P\u016fsob\u00ed blokov\u00e1n\u00edm enzymu DPP-4, kter\u00fd norm\u00e1ln\u011b rozkl\u00e1d\u00e1 inkretinov\u00e9 hormony (GLP-1 a GIP). Vy\u0161\u0161\u00ed hladiny inkretinu stimuluj\u00ed uvol\u0148ov\u00e1n\u00ed inzul\u00ednu a potla\u010duj\u00ed glukagon <strong>pouze kdy\u017e je hladina gluk\u00f3zy v krvi vysok\u00e1<\/strong> \u2014 tak\u017ee inhibitory DPP-4 maj\u00ed gluk\u00f3zo-z\u00e1visl\u00fd \u00fa\u010dinek a <strong>nezp\u016fsobuj\u00ed hypoglyk\u00e9mii<\/strong> jako monoterapie. Sn\u00ed\u017een\u00ed HbA1c: 0,6\u20130,8 bod\u016f. Neutr\u00e1ln\u00ed v\u016f\u010di hmotnosti. Jednor\u00e1zov\u00e9 denn\u00ed d\u00e1vkov\u00e1n\u00ed (v\u011bt\u0161ina gliptin\u016f). Jedin\u00fd DPP-4, kter\u00fd ne <strong>ne<\/strong> vy\u017eaduje \u00fapravu d\u00e1vky p\u0159i ren\u00e1ln\u00edm posti\u017een\u00ed \u2014 jedna tableta, jedna d\u00e1vka, jak\u00e1koli funkce ledvin. Kardiovaskul\u00e1rn\u011b neutr\u00e1ln\u00ed v v\u00fdsledkov\u00fdch studi\u00edch CARMELINA a CAROLINA. D\u00e1vka: 5 mg jednou denn\u011b \u2014 jedna fixn\u00ed d\u00e1vka bez ohledu na ren\u00e1ln\u00ed nebo jatern\u00ed funkci. Hlavn\u00ed vedlej\u0161\u00ed \u00fa\u010dinky jsou m\u00edrn\u00e9 \u2014 p\u0159\u00edznaky horn\u00edch cest d\u00fdchac\u00edch, bolest hlavy, vz\u00e1cn\u011b pankreatitida. Vyvarujte se u\u017e\u00edv\u00e1n\u00ed u diabetu 1. typu a DKA.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co je Trajenta?<\/h2>\n<p>Trajenta je peror\u00e1ln\u00ed antidiabetikum obsahuj\u00edc\u00ed <strong>linagliptin<\/strong> (5 mg), vyr\u00e1b\u011bn\u00e9 spole\u010dnost\u00ed Boehringer Ingelheim. Dostupn\u00e9 v balen\u00edch po 30, 60, 90 nebo 180 tablet\u00e1ch. P\u0159edepisuje se dosp\u011bl\u00fdm s diabetem 2. typu, obvykle spolu s metforminem nebo jako l\u00e9k druh\u00e9 \u010di t\u0159et\u00ed volby.<\/p>\n<p>linagliptin pat\u0159\u00ed do t\u0159\u00eddy inhibitor\u016f DPP-4 (\u201cgliptiny\u201d) \u2014 poprv\u00e9 schv\u00e1len v roce 2011 (origin\u00e1ln\u00ed zna\u010dka: Trajenta, Boehringer Ingelheim \/ Eli Lilly). Gliptiny jsou \u0161iroce pou\u017e\u00edv\u00e1ny, proto\u017ee jsou neutr\u00e1ln\u00ed v\u016f\u010di hmotnosti, maj\u00ed n\u00edzk\u00e9 riziko hypoglyk\u00e9mie a mohou b\u00fdt pou\u017eity v cel\u00e9m spektru ren\u00e1ln\u00edch funkc\u00ed s p\u0159\u00edslu\u0161nou \u00fapravou d\u00e1vky.<\/p>\n<h2 class=\"wp-block-heading\">Jak Trajenta funguje?<\/h2>\n<p>Po j\u00eddle st\u0159evo uvol\u0148uje dva inkretinov\u00e9 hormony \u2014 <strong>GLP-1 (glukagonu podobn\u00fd peptid-1)<\/strong> a <strong>GIP (gluk\u00f3za-dependentn\u00ed insulinotropn\u00ed peptid)<\/strong>. Tyto hormony signalizuj\u00ed slinivce, aby uvolnila inzulin, a j\u00e1tr\u016fm, aby potla\u010dila glukagon, ale jsou rychle rozkl\u00e1d\u00e1ny enzymem <strong>dipeptidyl peptid\u00e1zou-4 (DPP-4)<\/strong> b\u011bhem n\u011bkolika minut.<\/p>\n<p>linagliptin blokuje DPP-4. T\u00edm zvy\u0161uje hladiny aktivn\u00edho GLP-1 a GIP, co\u017e zp\u016fsobuje:<\/p>\n<ul>\n<li><strong>Gluk\u00f3za-dependentn\u00edmu uvol\u0148ov\u00e1n\u00ed inzulinu<\/strong> z beta bun\u011bk slinivky \u2014 pouze p\u0159i zv\u00fd\u0161en\u00e9 hladin\u011b gluk\u00f3zy v krvi<\/li>\n<li><strong>Potla\u010den\u00ed glukagonu<\/strong> z alfa bun\u011bk, co\u017e sni\u017euje jatern\u00ed produkci gluk\u00f3zy po j\u00eddle<\/li>\n<li>M\u00edrn\u00e9 zpomalen\u00ed vyprazd\u0148ov\u00e1n\u00ed \u017ealudku<\/li>\n<\/ul>\n<p>Proto\u017ee uvol\u0148ov\u00e1n\u00ed inzul\u00ednu je <em>z\u00e1visl\u00e9 na gluk\u00f3ze<\/em>, inhibitory DPP-4 samy o sob\u011b nezp\u016fsobuj\u00ed hypoglyk\u00e9mii. Typick\u00fd pokles HbA1c: <strong>0,6\u20130,8 procentn\u00edch bod\u016f<\/strong>. Vliv na hmotnost: neutr\u00e1ln\u00ed. Vliv na krevn\u00ed tlak a lipidy: neutr\u00e1ln\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed a pod\u00e1n\u00ed<\/h2>\n<p><strong>Standardn\u00ed d\u00e1vka:<\/strong> 5 mg jednou denn\u011b \u2014 jedna fixn\u00ed d\u00e1vka bez ohledu na ren\u00e1ln\u00ed nebo jatern\u00ed funkci. Trajenta lze u\u017e\u00edvat s j\u00eddlem nebo bez j\u00eddla.<\/p>\n<ul>\n<li>Jednou denn\u011b (dvakr\u00e1t denn\u011b u vildagliptinu) \u2014 vyberte si konzistentn\u00ed \u010das.<\/li>\n<li><strong>Polo\u010das a vylu\u010dov\u00e1n\u00ed:<\/strong> &gt; 100 hodin (dlouh\u00fd termin\u00e1ln\u00ed polo\u010das); ~80 % se vylu\u010duje nezm\u011bn\u011bno \u017elu\u010dovou\/stolicovou cestou \u2014 pouze asi 5 % ren\u00e1ln\u011b.<\/li>\n<li><strong>D\u00e1vkov\u00e1n\u00ed p\u0159i ren\u00e1ln\u00edm posti\u017een\u00ed:<\/strong> <strong>Nen\u00ed pot\u0159eba \u00fapravy d\u00e1vky p\u0159i \u017e\u00e1dn\u00e9 eGFR<\/strong> \u2014 linagliptin je DPP-4 volby pro CKD, v\u010detn\u011b dial\u00fdzy.<\/li>\n<li>U v\u011bt\u0161iny gliptin\u016f nen\u00ed nutn\u00e1 \u00faprava d\u00e1vkov\u00e1n\u00ed p\u0159i jatern\u00edm posti\u017een\u00ed (u vildagliptinu je nutn\u00e9 zkontrolovat v\u00fdchoz\u00ed hodnoty ALT).<\/li>\n<li>Pokud vynech\u00e1te d\u00e1vku, vynechejte ji a dal\u0161\u00ed u\u017eijte v obvyklou dobu. Nedvojte d\u00e1vku.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p>Inhibitory DPP-4 pat\u0159\u00ed mezi nejl\u00e9pe sn\u00e1\u0161en\u00e9 peror\u00e1ln\u00ed antidiabetika. V\u011bt\u0161ina ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f je m\u00edrn\u00e1 a podobn\u00e1 v r\u00e1mci cel\u00e9 t\u0159\u00eddy.<\/p>\n<p><strong>\u010cast\u00e9:<\/strong><\/p>\n<ul>\n<li>Infekce horn\u00edch cest d\u00fdchac\u00edch, nazofaryngitida<\/li>\n<li>Bolest hlavy<\/li>\n<li>M\u00edrn\u00e9 gastrointestin\u00e1ln\u00ed pot\u00ed\u017ee \u2013 nevolnost, pr\u016fjem (m\u00e9n\u011b \u010dast\u00e9 ne\u017e u metforminu)<\/li>\n<\/ul>\n<p><strong>M\u00e9n\u011b \u010dast\u00e9, ale d\u016fle\u017eit\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>Akutn\u00ed pankreatitida<\/strong> \u2013 vz\u00e1cn\u00fd, ale zdokumentovan\u00fd t\u0159\u00eddn\u00ed \u00fa\u010dinek; okam\u017eit\u011b p\u0159eru\u0161te l\u00e9\u010dbu, pokud se objev\u00ed siln\u00e1 bolest b\u0159icha<\/li>\n<li><strong>Siln\u00e1 bolest kloub\u016f (artralgie)<\/strong> \u2013 m\u016f\u017ee se objevit t\u00fddny a\u017e m\u011bs\u00edce po zah\u00e1jen\u00ed l\u00e9\u010dby; obvykle vymiz\u00ed po vysazen\u00ed l\u00e9ku<\/li>\n<li><strong>P\u0159ecitliv\u011blost \/ angioed\u00e9m<\/strong> \u2014 byl hl\u00e1\u0161en bul\u00f3zn\u00ed pemfigoid; p\u0159eru\u0161te l\u00e9\u010dbu, pokud se objev\u00ed puch\u00fd\u0159nat\u00e9 ko\u017en\u00ed l\u00e9ze<\/li>\n<li>Konkr\u00e9tn\u011b u saxagliptinu: m\u00edrn\u00e9 zv\u00fd\u0161en\u00ed hospitalizac\u00ed pro srde\u010dn\u00ed selh\u00e1n\u00ed<\/li>\n<li>Konkr\u00e9tn\u011b u vildagliptinu: vz\u00e1cn\u00e9 zv\u00fd\u0161en\u00ed jatern\u00edch enzym\u016f \u2014 sledujte ALT<\/li>\n<\/ul>\n<p>Jako monoterapie je hypoglyk\u00e9mie velmi vz\u00e1cn\u00e1. P\u0159i kombinaci se sulfonylmo\u010dovinami nebo inzulinem m\u016f\u017ee b\u00fdt nutn\u00e9 sn\u00ed\u017eit d\u00e1vky t\u011bchto l\u00e1tek.<\/p>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<ul>\n<li><strong>Sulfonylmo\u010doviny, inzulin, meglitinidy<\/strong> \u2014 aditivn\u00ed sn\u00ed\u017een\u00ed glyk\u00e9mie. P\u0159i p\u0159id\u00e1n\u00ed gliptinu o\u010dek\u00e1vejte nutnost sn\u00ed\u017een\u00ed t\u011bchto d\u00e1vek.<\/li>\n<li><strong>Siln\u00e9 inhibitory CYP3A4\/5<\/strong> (ketokonazol, klarithromycin, ritonavir, atazanavir) \u2014 zvy\u0161uj\u00ed hladiny saxagliptinu; sni\u017ete d\u00e1vku saxagliptinu na polovinu. Minim\u00e1ln\u00ed \u00fa\u010dinek na sitagliptin, linagliptin, vildagliptin.<\/li>\n<li><strong>Rifampicin<\/strong> \u2014 m\u00edrn\u011b sni\u017euje hladiny linagliptinu; \u00fa\u010dinek m\u016f\u017ee b\u00fdt klinicky v\u00fdznamn\u00fd.<\/li>\n<li><strong>ACE inhibitory<\/strong> \u2014 teoretick\u00e9 zv\u00fd\u0161en\u00ed rizika angioed\u00e9mu; klinick\u00fd v\u00fdznam je diskutabiln\u00ed.<\/li>\n<li><strong>Digoxin<\/strong> \u2014 m\u00edrn\u00e9 zv\u00fd\u0161en\u00ed vrcholov\u00e9 hladiny u sitagliptinu; obvykle nen\u00ed klinicky v\u00fdznamn\u00e9.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kdo by nem\u011bl u\u017e\u00edvat Trajentu?<\/h2>\n<ul>\n<li>Diabetes mellitus 1. typu<\/li>\n<li>Diabetick\u00e1 ketoacid\u00f3za<\/li>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na linagliptin nebo jin\u00e9 inhibitory DPP-4<\/li>\n<li>Historie pankreatitidy (relativn\u00ed kontraindikace \u2014 zva\u017ete alternativy)<\/li>\n<li>T\u011bhotenstv\u00ed a kojen\u00ed \u2014 data omezen\u00e1; preferuj\u00ed se alternativy<\/li>\n<li>Konkr\u00e9tn\u011b u saxagliptinu: t\u011b\u017ek\u00e9 srde\u010dn\u00ed selh\u00e1n\u00ed<\/li>\n<li>Konkr\u00e9tn\u011b u vildagliptinu: ALT nebo AST &gt; 3\u00d7 horn\u00ed hranice norm\u00e1lu<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte Trajentu p\u0159i teplot\u011b pod 30 \u00b0C na such\u00e9m m\u00edst\u011b, v p\u016fvodn\u00edm blistru. Uchov\u00e1vejte mimo dosah d\u011bt\u00ed.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Je Trajenta tot\u00e9\u017e co linagliptin?<\/h3>\n<p>Ano. Trajenta obsahuje stejnou \u00fa\u010dinnou l\u00e1tku jako origin\u00e1ln\u00ed zna\u010dka. Regula\u010dn\u00ed org\u00e1ny vy\u017eaduj\u00ed bioekvivalenci, tak\u017ee klinick\u00fd \u00fa\u010dinek je p\u0159i stejn\u00e9 d\u00e1vce stejn\u00fd.<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d zvolit linagliptin m\u00edsto sitagliptinu?<\/h3>\n<p>Hlavn\u00ed v\u00fdhodou linagliptinu je, \u017ee nevy\u017eaduje \u00fapravu d\u00e1vky p\u0159i onemocn\u011bn\u00ed ledvin \u2014 stejn\u00e1 tableta 5 mg funguje, a\u0165 je eGFR 90 nebo 15. Sitagliptin m\u00e1 rozs\u00e1hlej\u0161\u00ed data z v\u00fdsledkov\u00fdch studi\u00ed, ale vy\u017eaduje sn\u00ed\u017een\u00ed d\u00e1vky o 50 % nebo 75 % p\u0159i st\u0159edn\u011b t\u011b\u017ek\u00e9m a\u017e t\u011b\u017ek\u00e9m CKD. U pacient\u016f se stabiln\u00ed ren\u00e1ln\u00ed funkc\u00ed jsou oba l\u00e9ky klinicky podobn\u00e9.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017ee Trajenta zp\u016fsobit n\u00edzkou hladinu cukru v krvi?<\/h3>\n<p>Samotn\u00e1 ne. Inhibitory DPP-4 p\u016fsob\u00ed gluk\u00f3zo-z\u00e1visl\u00fdm zp\u016fsobem \u2014 zesiluj\u00ed uvol\u0148ov\u00e1n\u00ed inzul\u00ednu pouze p\u0159i vysok\u00e9 hladin\u011b gluk\u00f3zy v krvi. Hypoglyk\u00e9mie se st\u00e1v\u00e1 probl\u00e9mem pouze p\u0159i kombinaci Trajenty se sulfonylmo\u010dovinou, meglitinidem nebo inzul\u00ednem.<\/p>\n<h3 class=\"wp-block-heading\">Zp\u016fsobuje Trajenta p\u0159ib\u00fdv\u00e1n\u00ed na v\u00e1ze?<\/h3>\n<p>Ne \u2014 inhibitory DPP-4 jsou neutr\u00e1ln\u00ed z hlediska hmotnosti. To je jeden z hlavn\u00edch d\u016fvod\u016f, pro\u010d jsou u pacient\u016f s nadv\u00e1hou preferov\u00e1ny p\u0159ed sulfonylureami.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017ee Trajenta zp\u016fsobit pankreatitidu?<\/h3>\n<p>Akutn\u00ed pankreatitida je vz\u00e1cn\u00fd, ale zdokumentovan\u00fd t\u0159\u00eddn\u00ed \u00fa\u010dinek. Absolutn\u00ed riziko je mal\u00e9 a rozs\u00e1hl\u00e9 studie (TECOS, CARMELINA, SAVOR) obecn\u011b neprok\u00e1zaly statisticky v\u00fdznamn\u00e9 zv\u00fd\u0161en\u00ed. P\u0159i rozvoji siln\u00e9 bolesti b\u0159icha \u2014 zejm\u00e9na bolesti vyza\u0159uj\u00edc\u00ed do zad \u2014 okam\u017eit\u011b p\u0159eru\u0161te l\u00e9\u010dbu a vyhledejte l\u00e9ka\u0159skou pomoc.<\/p>\n<h3 class=\"wp-block-heading\">Za jak dlouho za\u010dne Trajenta p\u016fsobit?<\/h3>\n<p>Hladina gluk\u00f3zy nala\u010dno za\u010dne klesat b\u011bhem prvn\u00edho t\u00fddne. Maxim\u00e1ln\u00ed \u00fa\u010dinek na HbA1c je po 12 t\u00fddnech. Pokud HbA1c neklesne alespo\u0148 o 0,3\u20130,5 % po 3 m\u011bs\u00edc\u00edch, m\u011bla by b\u00fdt zv\u00e1\u017eena jin\u00e1 l\u00e9\u010dba (inhibitor SGLT-2 nebo agonista GLP-1).<\/p>\n<h3 class=\"wp-block-heading\">Mohu n\u00e1hle p\u0159estat u\u017e\u00edvat Trajentu, pokud se nec\u00edt\u00edm dob\u0159e?<\/h3>\n<p>Ano \u2014 inhibitory DPP-4 lze vysadit n\u00e1hle bez rizika rebound hyperglyk\u00e9mie. Pokud se objev\u00ed siln\u00e1 bolest b\u0159icha, puch\u00fd\u0159e na k\u016f\u017ei nebo siln\u00e1 bolest kloub\u016f, p\u0159esta\u0148te l\u00e9k u\u017e\u00edvat a kontaktujte l\u00e9ka\u0159e.<\/p>\n<h3 class=\"wp-block-heading\">Kde si mohu koupit Trajenta online?<\/h3>\n<p>Trajenta (5 mg) si m\u016f\u017eete objednat na MedsBase v balen\u00edch po 30, 60, 90 nebo 180 tablet\u00e1ch. Dod\u00e1v\u00e1me po cel\u00e9m sv\u011bt\u011b, s diskr\u00e9tn\u00edm balen\u00edm a origin\u00e1ln\u00edmi z\u00e1sobami od v\u00fdrobce certifikovan\u00e9ho WHO-GMP.<\/p>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed l\u00e9ky na diabetes<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/januvia\/\">Januvia \u2014 Sitagliptin 25\/50\/100 mg (Merck)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/trajenta\/\">Trajenta \u2014 Linagliptin 5 mg (Boehringer Ingelheim)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/galvus\/\">Galvus \u2014 Vildagliptin 50 mg (Novartis)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/janumet\/\">Janumet \u2014 Kombinace sitagliptinu a metforminu<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/jardiance-empagliflozin\/\">Jardiance \u2014 Empagliflozin (alternativa SGLT-2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/glycomet-sr\/\">Glycomet SR \u2014 Metformin s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/diabetes-medication\/\"><strong>Prohl\u00e9dnout v\u0161echny l\u00e9ky na diabetes<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 L\u00e9ka\u0159sk\u00e9 upozorn\u011bn\u00ed.<\/strong> Tato str\u00e1nka slou\u017e\u00ed pouze pro informa\u010dn\u00ed \u00fa\u010dely a nenahrazuje l\u00e9ka\u0159skou p\u00e9\u010di kvalifikovan\u00e9ho zdravotnick\u00e9ho pracovn\u00edka. Inhibitory DPP-4 jsou spojov\u00e1ny se vz\u00e1cnou pankreatitidou, silnou bolest\u00ed kloub\u016f a bul\u00f3zn\u00edm pemfigoidem \u2014 v\u017edy u\u017e\u00edvejte pod l\u00e9ka\u0159sk\u00fdm dohledem a p\u0159i v\u00fdskytu t\u011bchto p\u0159\u00edznak\u016f okam\u017eit\u011b p\u0159eru\u0161te l\u00e9\u010dbu a vyhledejte l\u00e9ka\u0159e.<\/div>","protected":false},"excerpt":{"rendered":"<h5>\u2705 Reguluje hladinu cukru v krvi<br \/>\n\u2705 Podporuje l\u00e9\u010dbu diabetu<br \/>\n\u2705 Zlep\u0161uje funkci inzul\u00ednu<br \/>\n\u2705 Mo\u017enost jednodenn\u00edho d\u00e1vkov\u00e1n\u00ed<br \/>\n\u2705 Zlep\u0161uje kontrolu glyk\u00e9mie<\/h5>\n<p><span style=\"color: #999999;\">Trajenta obsahuje Linagliptin<\/span><\/p>","protected":false},"featured_media":50772,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[3278],"class_list":{"0":"post-50771","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-linagliptin","12":"first","13":"outofstock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/50771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=50771"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/50772"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=50771"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=50771"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=50771"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=50771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}